[
  {
    "name": "ramipril",
    "tags": ["cardio", "renal", "safety"],
    "anchors": [
      {
        "id": "class",
        "title": "Drug class",
        "prompt": "Which class does ramipril belong to?",
        "type": "single",
        "options": [
          { "id": "ace", "label": "ACE inhibitor" },
          { "id": "arb", "label": "Angiotensin II receptor blocker (ARB)" },
          { "id": "ccb", "label": "Dihydropyridine calcium-channel blocker" },
          { "id": "bb", "label": "Beta-blocker" }
        ],
        "correct": ["ace"],
        "explanation": "Ramipril is an ACE inhibitor (prodrug → ramiprilat)."
      },
      {
        "id": "indications",
        "title": "Common indications",
        "prompt": "Select ALL common indications.",
        "type": "multi",
        "options": [
          { "id": "htn", "label": "Hypertension" },
          { "id": "hfrEF", "label": "Heart failure with reduced EF" },
          { "id": "postmi", "label": "Post-MI / secondary prevention" },
          { "id": "ckd", "label": "CKD with albuminuria (incl. diabetic nephropathy)" },
          { "id": "angina", "label": "Stable angina" }
        ],
        "correct": ["htn", "hfrEF", "postmi", "ckd"],
        "explanation": "HTN, HFrEF, post-MI, CKD with albuminuria are standard indications."
      },
      {
        "id": "moa",
        "title": "Mechanism of action",
        "prompt": "Which statement best describes the mechanism?",
        "type": "single",
        "options": [
          { "id": "moa_true", "label": "Inhibits ACE → ↓Ang II & ↓aldosterone + ↑bradykinin → vasodilation" },
          { "id": "moa_arb", "label": "Blocks AT1 receptor (ARB)" },
          { "id": "moa_ccb", "label": "Blocks L-type Ca²⁺ channels" }
        ],
        "correct": ["moa_true"],
        "explanation": "ACE inhibition lowers Ang II/aldosterone; bradykinin rises."
      },
      {
        "id": "adrs",
        "title": "Important adverse reactions",
        "prompt": "Select ALL clinically important ADRs.",
        "type": "multi",
        "options": [
          { "id": "cough", "label": "Dry cough" },
          { "id": "angio", "label": "Angioedema" },
          { "id": "k", "label": "Hyperkalaemia" },
          { "id": "hypo", "label": "Symptomatic hypotension" },
          { "id": "renal", "label": "Rise in creatinine/AKI risk" }
        ],
        "correct": ["cough", "angio", "k", "hypo", "renal"],
        "explanation": "Cough/angioedema (bradykinin), hyperkalaemia, hypotension, creatinine rise."
      },
      {
        "id": "interactions",
        "title": "Important drug–drug interactions",
        "prompt": "Select ALL interactions of concern.",
        "type": "multi",
        "options": [
          { "id": "kplus", "label": "K⁺ supplements / K-sparing diuretics (e.g., spironolactone)" },
          { "id": "nsaids", "label": "NSAIDs (esp. chronic)" },
          { "id": "lithium", "label": "Lithium" },
          { "id": "dualraas", "label": "Dual RAAS blockade (ARB/aliskiren)" }
        ],
        "correct": ["kplus", "nsaids", "lithium", "dualraas"],
        "explanation": "↑K⁺ risk; NSAIDs blunt effect & ↑AKI; lithium ↑; avoid dual RAAS."
      }
    ]
  },
  {
    "name": "atorvastatin",
    "tags": ["cardio"],
    "anchors": [
      {
        "id": "class",
        "title": "Drug class",
        "prompt": "Which class does atorvastatin belong to?",
        "type": "single",
        "options": [
          { "id": "statin", "label": "HMG-CoA reductase inhibitor (statin)" },
          { "id": "ezet",  "label": "Cholesterol absorption inhibitor (ezetimibe)" },
          { "id": "pcsk9", "label": "PCSK9 inhibitor" },
          { "id": "ace",   "label": "ACE inhibitor" },
          { "id": "ccb",   "label": "Calcium-channel blocker" }
        ],
        "correct": ["statin"],
        "explanation": "Atorvastatin is a statin."
      },
      {
        "id": "indications",
        "title": "Common indications",
        "prompt": "Select ALL common indications.",
        "type": "multi",
        "options": [
          { "id": "hyperlipid", "label": "Primary hypercholesterolaemia" },
          { "id": "fh",         "label": "Familial hypercholesterolaemia (adjunct)" },
          { "id": "prevention", "label": "CV risk reduction / secondary prevention" },
          { "id": "angina",     "label": "Stable angina treatment" },
          { "id": "pain",       "label": "Analgesia" }
        ],
        "correct": ["hyperlipid", "fh", "prevention"],
        "explanation": "Lipid lowering (incl. familial forms); cardiovascular risk reduction."
      },
      {
        "id": "moa",
        "title": "Mechanism of action",
        "prompt": "Which statement best describes the mechanism?",
        "type": "single",
        "options": [
          { "id": "moa_true", "label": "Inhibits HMG-CoA reductase → ↓cholesterol synthesis; ↑LDL receptors" },
          { "id": "moa_upreg","label": "Upregulates hepatic LDL receptors increasing LDL clearance" },
          { "id": "moa_ace",  "label": "Inhibits ACE" },
          { "id": "moa_ccb",  "label": "Blocks L-type Ca²⁺ channels" }
        ],
        "correct": ["moa_true"],
        "explanation": "Primary action is HMG-CoA reductase inhibition; LDL-receptor upregulation follows."
      },
      {
        "id": "adrs",
        "title": "Important adverse reactions",
        "prompt": "Select ALL clinically important ADRs.",
        "type": "multi",
        "options": [
          { "id": "myopathy", "label": "Myalgia/myopathy (rare rhabdomyolysis)" },
          { "id": "lfts",     "label": "↑Transaminases/hepatotoxicity" },
          { "id": "gi",       "label": "GI upset" },
          { "id": "dm",       "label": "Small increase in diabetes risk" },
          { "id": "cough",    "label": "Dry cough" }
        ],
        "correct": ["myopathy", "lfts", "gi", "dm"],
        "explanation": "Muscle symptoms, LFT elevation, GI upset; slight ↑ risk of new-onset diabetes."
      },
            {
        "id": "interactions",
        "title": "Important drug–drug interactions",
        "prompt": "Select ALL interactions of concern.",
        "type": "multi",
        "options": [
          { "id": "cyp3a4",   "label": "Strong CYP3A4 inhibitors (e.g., clarithromycin, azoles, protease inhibitors)" },
          { "id": "gfj",      "label": "Grapefruit juice (large amounts)" },
          { "id": "fibrates", "label": "Fibrates (e.g., gemfibrozil)" },
          { "id": "warfarin", "label": "Warfarin" }
        ],
        "correct": ["cyp3a4", "gfj", "fibrates"],
        "explanation": "CYP3A4 inhibitors & grapefruit raise statin levels; fibrates add myopathy risk."
      }
    ]
  },
  {
    "name": "metformin",
    "tags": ["endocrine"],
    "anchors": [     
    {
      "id": "class",
      "title": "Drug class",
      "prompt": "Which class does metformin belong to?",
      "type": "single",
      "options": [
        { "id": "big", "label": "Biguanide" },
        { "id": "sulf", "label": "Sulfonylurea" },
        { "id": "dpp4", "label": "DPP-4 inhibitor" }
      ],
      "correct": ["big"],
      "explanation": "Metformin is a biguanide."
    },
    {
      "id": "indications",
      "title": "Common indications",
      "prompt": "Select ALL common indications.",
      "type": "multi",
      "options": [
        { "id": "t2dm", "label": "Type 2 diabetes (first-line)" },
        { "id": "pco", "label": "Polycystic ovary syndrome (off-label)" },
        { "id": "t1dm", "label": "Type 1 diabetes" }
      ],
      "correct": ["t2dm", "pco"],
      "explanation": "First-line for T2DM; sometimes used in PCOS."
    },
    {
      "id": "moa",
      "title": "Mechanism of action",
      "prompt": "Which statement best describes the mechanism?",
      "type": "single",
      "options": [
        { "id": "ampk", "label": "Activates AMPK → ↓hepatic gluconeogenesis; ↑peripheral uptake" },
        { "id": "ins", "label": "Stimulates pancreatic insulin release" },
        { "id": "slgt2", "label": "Inhibits renal glucose reabsorption" }
      ],
      "correct": ["ampk"],
      "explanation": "AMPK activation reduces hepatic glucose output."
    },
    {
      "id": "adrs",
      "title": "Important adverse reactions",
      "prompt": "Select ALL clinically important ADRs.",
      "type": "multi",
      "options": [
        { "id": "gi", "label": "GI upset (nausea/diarrhoea)" },
        { "id": "la", "label": "Lactic acidosis (rare; caution in renal impairment)" },
        { "id": "hypo", "label": "Hypoglycaemia" },
        { "id": "b12", "label": "↓Vitamin B12 levels" }
      ],
      "correct": ["gi", "la", "b12"],
      "explanation": "GI effects common; rare lactic acidosis; B12 can fall."
    },
    {
      "id": "interactions",
      "title": "Important drug–drug interactions",
      "prompt": "Select ALL interactions of concern.",
      "type": "multi",
      "options": [
        { "id": "ivcontrast", "label": "Iodinated contrast in renal impairment" },
        { "id": "alcohol", "label": "Excess alcohol" },
        { "id": "cimet", "label": "Cimetidine" }
      ],
      "correct": ["ivcontrast", "alcohol"],
      "explanation": "Contrast & alcohol ↑ lactic acidosis risk."
    }
  ]
},
{
  "name": "bisoprolol",
  "tags": ["cardio"],
  "anchors": [
    {
      "id": "class",
      "title": "Drug class",
      "prompt": "Which class does bisoprolol belong to?",
      "type": "single",
      "options": [
        { "id": "bb1", "label": "β1-selective beta-blocker" },
        { "id": "ccb", "label": "Calcium-channel blocker" },
        { "id": "ace", "label": "ACE inhibitor" }
      ],
      "correct": ["bb1"],
      "explanation": "β1-selective beta-blocker."
    },
    {
      "id": "indications",
      "title": "Common indications",
      "prompt": "Select ALL common indications.",
      "type": "multi",
      "options": [
        { "id": "htn", "label": "Hypertension (adjunct)" },
        { "id": "angina", "label": "Angina" },
        { "id": "hf", "label": "Heart failure with reduced EF" },
        { "id": "af", "label": "Rate control in AF" }
      ],
      "correct": ["htn", "angina", "hf", "af"],
      "explanation": "Used across HTN/angina/HFrEF/rate control."
    },
    {
      "id": "moa",
      "title": "Mechanism of action",
      "prompt": "Which statement best describes the mechanism?",
      "type": "single",
      "options": [
        { "id": "b1", "label": "Blocks cardiac β1 receptors → ↓HR/contractility" },
        { "id": "vaso", "label": "Direct arterial vasodilator" },
        { "id": "diur", "label": "Inhibits Na⁺/Cl⁻ cotransporter (DCT)" }
      ],
      "correct": ["b1"],
      "explanation": "Negative chronotrope/inotrope via β1 blockade."
    },
    {
      "id": "adrs",
      "title": "Important adverse reactions",
      "prompt": "Select ALL clinically important ADRs.",
      "type": "multi",
      "options": [
        { "id": "brady", "label": "Bradycardia" },
        { "id": "fatigue", "label": "Fatigue" },
        { "id": "bronch", "label": "Bronchospasm (caution in asthma)" },
        { "id": "impot", "label": "Sexual dysfunction" }
      ],
      "correct": ["brady", "fatigue", "bronch", "impot"],
      "explanation": "Class effects of beta-blockers."
    },
    {
      "id": "interactions",
      "title": "Important drug–drug interactions",
      "prompt": "Select ALL interactions of concern.",
      "type": "multi",
      "options": [
        { "id": "ccbn", "label": "Non-DHP CCBs (verapamil/diltiazem)" },
        { "id": "dig", "label": "Digoxin" },
        { "id": "clon", "label": "Clonidine (withdrawal)" }
      ],
      "correct": ["ccbn", "dig", "clon"],
      "explanation": "Additive AV nodal effects; clonidine rebound."
    }
  ]
},
{
  "name": "omeprazole",
  "tags": ["gi"],
  "anchors": [
    {
      "id": "class",
      "title": "Drug class",
      "prompt": "Which class does omeprazole belong to?",
      "type": "single",
      "options": [
        { "id": "ppi", "label": "Proton pump inhibitor" },
        { "id": "h2", "label": "H2 receptor antagonist" },
        { "id": "antacid", "label": "Antacid" }
      ],
      "correct": ["ppi"],
      "explanation": "Irreversibly blocks gastric H⁺/K⁺ ATPase."
    },
    {
      "id": "indications",
      "title": "Common indications",
      "prompt": "Select ALL common indications.",
      "type": "multi",
      "options": [
        { "id": "gord", "label": "GORD/peptic ulcer disease" },
        { "id": "hpy", "label": "H. pylori eradication (triple therapy)" },
        { "id": "nsaid", "label": "NSAID gastroprotection" },
        { "id": "constip", "label": "Constipation" }
      ],
      "correct": ["gord", "hpy", "nsaid"],
      "explanation": "Standard acid-suppression indications."
    },
    {
      "id": "moa",
      "title": "Mechanism of action",
      "prompt": "Which statement best describes the mechanism?",
      "type": "single",
      "options": [
        { "id": "ptrue", "label": "Irreversible inhibition of gastric H⁺/K⁺ ATPase (parietal cells)" },
        { "id": "h2blk", "label": "Blocks H2 receptors" },
        { "id": "base", "label": "Neutralises gastric acid" }
      ],
      "correct": ["ptrue"],
      "explanation": "Covalent binding to the proton pump."
    },
    {
      "id": "adrs",
      "title": "Important adverse reactions",
      "prompt": "Select ALL clinically important ADRs.",
      "type": "multi",
      "options": [
        { "id": "cdi", "label": "↑Risk of C. difficile" },
        { "id": "fract", "label": "Fracture risk (long-term/high dose)" },
        { "id": "hypomg", "label": "Hypomagnesaemia (long-term)" },
        { "id": "rash", "label": "Rash" }
      ],
      "correct": ["cdi", "fract", "hypomg"],
      "explanation": "Long-term safety considerations."
    },
    {
      "id": "interactions",
      "title": "Important drug–drug interactions",
      "prompt": "Select ALL interactions of concern.",
      "type": "multi",
      "options": [
        { "id": "clop", "label": "Clopidogrel (CYP2C19 interaction)" },
        { "id": "war", "label": "Warfarin (monitor INR)" },
        { "id": "ket", "label": "Drugs needing acidic pH (e.g., ketoconazole)" }
      ],
      "correct": ["clop", "ket"],
      "explanation": "Reduces clopidogrel activation; raises gastric pH."
    }
  ]
}
]

